Valuation Evotec SE Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate Other stock markets 10:52:17 2026-08-10 EDT			5-day change	1st Jan Change
3.721 ^EUR	+5.65%		+5.78%	-32.97%

08-06	Evotec, Odyssey Therapeutics Partner to Develop Autoimmune, Inflammatory Disease Treatments	MT
08-06	Evotec, Odyssey Therapeutics Team Up on Autoimmune, Inflammatory Disease Treatment Research	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	7,444	2,696	3,765	1,453	966.4	615.7	-	-
Change	-	-63.78%	39.63%	-61.41%	-33.49%	-36.29%	-	-
Enterprise Value (EV) ¹	7,099	2,485	3,787	1,669	938.7	657.2	720.9	708.9
Change	-	-65%	52.43%	-55.93%	-43.75%	-29.99%	9.69%	-1.66%
P/E	32.7x	-15.4x	-45.3x	-7.38x	-9.4x	-4.02x	-10x	48.8x
PBR	5.44x	2.27x	3.37x	6.89x	1.19x	1.09x	1.09x	1.07x
PEG	-	0x	0.9x	-0x	0.2x	-0.1x	0.2x	-0x
Capitalization / Revenue	12x	3.59x	4.82x	1.82x	1.23x	1.03x	0.84x	0.77x
EV / Revenue	11.5x	3.31x	4.85x	2.09x	1.19x	1.1x	0.98x	0.88x
EV / EBITDA	66.2x	24.4x	57.1x	74x	22.8x	-12.5x	11x	6.37x
EV / EBIT	173x	119x	-142x	-11.7x	-16.7x	-4.72x	-25.4x	20.8x
EV / FCF	2,155x	114x	-21.4x	-16.8x	-11.5x	-4.88x	-22.9x	23.3x
FCF Yield	0.05%	0.88%	-4.67%	-5.95%	-8.71%	-20.5%	-4.37%	4.3%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.3	-0.99	-0.47	-1.11	-0.58	-0.8615	-0.3453	0.071
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	618	751.4	781.4	797	788.4	599.7	736.1	801.5
EBITDA ¹	107.3	101.7	66.35	22.56	41.1	-52.58	65.68	111.3
EBIT ¹	41	20.85	-26.63	-142.5	-56.2	-139.1	-28.34	34.08
Net income ¹	215.5	-175.7	-83.91	-196.1	-103.5	-147.2	-47.45	23.13
Net Debt ¹	-345.3	-211.8	22.09	216	-27.66	41.5	105.2	93.2
Reference price ²	42.500	15.260	21.280	8.195	5.450	3.464	3.464	3.464
Nbr of stocks (in thousands)	175,162	176,703	176,936	177,303	177,323	177,749	-	-
Announcement Date	4/12/22	5/12/23	4/24/24	4/17/25	4/8/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LONZA GROUP AG	33.6x	6x	17.84x	0.95%	49.47B
REVOLUTION MEDICINES, INC.	-21.68x	304.44x	-21.6x	-.--%	43.97B
BEONE MEDICINES AG	46.07x	5.25x	28.89x	-.--%	39.6B
IQVIA HOLDINGS INC.	30.74x	3.05x	13.16x	-.--%	39.29B
CELLTRION, INC.	30.33x	8.75x	21.99x	0.38%	32.43B
MEDPACE HOLDINGS, INC.	33.59x	5.5x	24.99x	-.--%	16.49B
EUROFINS SCIENTIFIC SE	23.22x	2.04x	8.82x	1.16%	14.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	65.72x	3.81x	14.73x	-.--%	12.77B
Average	30.20x	42.35x	13.60x	0.31%	31B
Weighted average by Cap.	25.98x	58.31x	12.22x	0.31%